论文部分内容阅读
目的观察蒲元和胃胶囊联合三联疗法治疗幽门螺旋杆菌感染性萎缩性胃炎的临床效果。方法选取医院收治的符合诊断标准的幽门螺旋杆菌感染性萎缩性胃炎患者103例,随机分为观察组52例和对照组51例。对照组应用三联疗法治疗,观察组应用蒲元和胃胶囊联合三联疗法治疗,观察比较2组的临床治疗效果。结果观察组总有效率为92.31%,高于对照组的74.51%,差异有统计学意义(P<0.05)。结论蒲元和胃胶囊联合三联疗法治疗幽门螺旋杆菌感染性萎缩性胃炎的临床效果显著,值得推广。
Objective To observe the clinical effect of Puyuanhewei capsule combined with triple therapy in treating Helicobacter pylori infection atrophic gastritis. Methods A total of 103 patients with H. pylori infection atrophic gastritis were enrolled in our hospital and were randomly divided into observation group (n = 52) and control group (n = 51). The control group was treated with triple therapy, and the observation group was treated with Puyuan and stomach capsule combined with triple therapy. The clinical effects of the two groups were observed and compared. Results The total effective rate in observation group was 92.31%, which was higher than that in control group (74.51%), the difference was statistically significant (P <0.05). Conclusion Po-yuan and stomach capsule triple therapy for the treatment of Helicobacter pylori infection atrophic gastritis clinical effect is significant and worth promoting.